{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:57:38Z","timestamp":1792364258568,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA 1876\/12-1"],"award-info":[{"award-number":["MA 1876\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2020.070"],"award-info":[{"award-number":["2020.070"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>KMT2A<\/jats:italic>-rearranged acute lymphoblastic infant leukemia (<jats:italic>KMT2A<\/jats:italic>-r iALL) is associated with outsize risk of relapse and relapse mortality. We previously reported strong upregulation of the immediate early gene <jats:italic>EGR3<\/jats:italic> in <jats:italic>KMT2A<\/jats:italic>::<jats:italic>AFF1<\/jats:italic> iALL at relapse; now we provide analyses of the EGR3 regulome, which we assessed through binding and expression target analysis of an EGR3-overexpressing t(4;11) cell culture model. Our data identify EGR3 as a regulator of early B-lineage commitment. Principal component analysis of 50 <jats:italic>KMT2A<\/jats:italic>-r iALL patients at diagnosis and 18 at relapse provided strictly dichotomous separation of patients based on the expression of four B-lineage genes. Absence of B-lineage gene expression translates to more than two-fold poorer long-term event-free survival. In conclusion, our study presents four B-lineage genes with prognostic significance, suitable for gene expression-based risk stratification of <jats:italic>KMT2A<\/jats:italic>-r iALL patients.<\/jats:p>","DOI":"10.1038\/s41375-023-01895-z","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T13:03:21Z","timestamp":1682514201000},"page":"1216-1233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-8412","authenticated-orcid":false,"given":"Marius","family":"K\u00fclp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Larghero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Alten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Cario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5996-3037","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Caye-Eude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-1511","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Cav\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Schmachtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6942-2274","authenticated-orcid":false,"given":"Michela","family":"Bardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halvard","family":"Bonig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4158-5872","authenticated-orcid":false,"given":"Michael A.","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-3445","authenticated-orcid":false,"given":"Rolf","family":"Marschalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"1895_CR1","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1200\/JCO.19.00261","volume":"37","author":"R Pieters","year":"2019","unstructured":"Pieters R, De Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, et al. Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study. J Clin Oncol. 2019;37:2246\u201356.","journal-title":"J Clin Oncol"},{"key":"1895_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","volume":"370","author":"R Pieters","year":"2007","unstructured":"Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007;370:240\u201350.","journal-title":"Lancet"},{"key":"1895_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/leu.2017.213","volume":"32","author":"C Meyer","year":"2018","unstructured":"Meyer C, Burmeister T, Gr\u00f6ger D, Tsaur G, Fechina L, Renneville A, et al. The MLL recombinome of acute leukemias in 2017. Leukemia. 2018;32:273\u201384.","journal-title":"Leukemia"},{"key":"1895_CR4","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/leu.2015.246","volume":"30","author":"EMC Driessen","year":"2016","unstructured":"Driessen EMC, de Lorenzo P, Campbell M, Felice M, Ferster A, Hann I, et al. Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol. Leukemia. 2016;30:1184\u20137.","journal-title":"Leukemia"},{"key":"1895_CR5","doi-asserted-by":"publisher","first-page":"104613","DOI":"10.1016\/j.isci.2022.104613","volume":"25","author":"M K\u00fclp","year":"2022","unstructured":"K\u00fclp M, Siemund AL, Larghero P, Dietz A, Alten J, Cario G, et al. The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia. iScience. 2022;25:104613.","journal-title":"iScience"},{"key":"1895_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0197-0186(96)00136-2","volume":"31","author":"AM Beckmann","year":"1997","unstructured":"Beckmann AM, Wilce PA. Egr transcription factors in the nervous system. Neurochem Int. 1997;31:477\u2013510.","journal-title":"Neurochem Int"},{"key":"1895_CR7","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1046\/j.1471-4159.2000.0751352.x","volume":"75","author":"KJ O\u2019Donovan","year":"2000","unstructured":"O\u2019Donovan KJ, Levkovitz Y, Ahn D, Baraban JM. Functional comparison of Egr3 transcription factor isoforms: identification of an activation domain in the N-terminal segment absent from Egr3beta, a major isoform expressed in brain. J Neurochem. 2000;75:1352\u20137.","journal-title":"J Neurochem"},{"key":"1895_CR8","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1523\/JNEUROSCI.5187-07.2008","volume":"28","author":"A Desmazi\u00e8res","year":"2008","unstructured":"Desmazi\u00e8res A, Decker L, Vallat JM, Charnay P, Gilardi-Hebenstreit P. Disruption of Krox20\u2013Nab interaction in the mouse leads to peripheral neuropathy with biphasic evolution. J Neurosci. 2008;28:5891\u2013900.","journal-title":"J Neurosci"},{"key":"1895_CR9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nn1490","volume":"8","author":"N Le","year":"2005","unstructured":"Le N, Nagarajan R, Wang JYT, Svaren J, LaPash C, Araki T, et al. Nab proteins are essential for peripheral nervous system myelination. Nat Neurosci. 2005;8:932\u201340.","journal-title":"Nat Neurosci"},{"key":"1895_CR10","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1128\/MCB.16.7.3545","volume":"16","author":"J Svaren","year":"1996","unstructured":"Svaren J, Sevetson BR, Apel ED, Zimonjic DB, Popescu NC, Milbrandt J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol. 1996;16:3545\u201353.","journal-title":"Mol Cell Biol"},{"key":"1895_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1128\/MCB.18.1.512","volume":"18","author":"AH Swirnoff","year":"1998","unstructured":"Swirnoff AH, Apel ED, Svaren J, Sevetson BR, Zimonjic DB, Popescu NC, et al. Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain. Mol Cell Biol. 1998;18:512\u201324.","journal-title":"Mol Cell Biol"},{"key":"1895_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0166-4328(02)00421-7","volume":"142","author":"S Davis","year":"2003","unstructured":"Davis S, Bozon B, Laroche S. How necessary is the activation of the immediate early gene zif268 in synaptic plasticity and learning? Behav Brain Res. 2003;142:17\u201330.","journal-title":"Behav Brain Res"},{"key":"1895_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pneurobio.2004.05.007","volume":"74","author":"E Knapska","year":"2004","unstructured":"Knapska E, Kaczmarek L. A gene for neuronal plasticity in the mammalian brain: Zif268\/Egr-1\/NGFI-A\/Krox-24\/TIS8\/ZENK? Prog Neurobiol. 2004;74:183\u2013211.","journal-title":"Prog Neurobiol"},{"key":"1895_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/0092-8674(93)90329-O","volume":"75","author":"S Schneider-Maunoury","year":"1993","unstructured":"Schneider-Maunoury S, Topilko P, Seitandou T, Levi G, Cohen-Tannoudji M, Pournin S, et al. Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell. 1993;75:1199\u2013214.","journal-title":"Cell"},{"key":"1895_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0169-328X(94)00187-J","volume":"28","author":"J Williams","year":"1995","unstructured":"Williams J, Dragunow M, Lawlor P, Mason S, Abraham WC, Leah J, et al. Krox20 may play a key role in the stabilization of long-term potentiation. Mol Brain Res. 1995;28:87\u201393.","journal-title":"Mol Brain Res"},{"key":"1895_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1101\/lm.1.2.140","volume":"1","author":"K Yamagata","year":"1994","unstructured":"Yamagata K, Kaufmann WE, Lanahan A, Papapavlou M, Barnes CA, Andreasson KI, et al. Egr3\/Pilot, a zinc finger transcription factor, is rapidly regulated by activity in brain neurons and colocalizes with Egr1\/zif268. Learn Mem. 1994;1:140\u201352.","journal-title":"Learn Mem"},{"key":"1895_CR17","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1182\/blood-2015-01-623645","volume":"126","author":"H Cheng","year":"2015","unstructured":"Cheng H, Hao S, Liu Y, Pang Y, Ma S, Dong F, et al. Leukemic marrow infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoietic stem cell proliferation. Blood 2015;126:1302\u201313.","journal-title":"Blood"},{"key":"1895_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.stem.2008.01.015","volume":"2","author":"IM Min","year":"2008","unstructured":"Min IM, Pietramaggiori G, Kim FS, Passegu\u00e9 E, Stevenson KE, Wagers AJ. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell. 2008;2:380\u201391.","journal-title":"Cell Stem Cell"},{"key":"1895_CR19","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.4049\/jimmunol.178.11.6796","volume":"178","author":"JH Carter","year":"2007","unstructured":"Carter JH, Lefebvre JM, Wiest DL, Tourtellotte WG. Redundant role for early growth response transcriptional regulators in thymocyte differentiation and survival. J Immunol. 2007;178:6796\u2013805.","journal-title":"J Immunol"},{"key":"1895_CR20","doi-asserted-by":"publisher","first-page":"e18498","DOI":"10.1371\/journal.pone.0018498","volume":"6","author":"S Li","year":"2011","unstructured":"Li S, Symonds ALJ, Zhu B, Liu M, Raymond MV, Miao T, et al. Early growth response Gene-2 (Egr-2) regulates the development of B and T cells. PLoS One. 2011;6:e18498.","journal-title":"PLoS One"},{"key":"1895_CR21","doi-asserted-by":"publisher","first-page":"20455","DOI":"10.1074\/jbc.M114.634816","volume":"290","author":"A Ogbe","year":"2015","unstructured":"Ogbe A, Miao T, Symonds ALJ, Omodho B, Singh R, Bhullar P, et al. Early growth response Genes 2 and 3 regulate the expression of Bcl6 and differentiation of T follicular helper cells. J Biol Chem. 2015;290:20455\u201365.","journal-title":"J Biol Chem"},{"key":"1895_CR22","doi-asserted-by":"publisher","first-page":"W566","DOI":"10.1093\/nar\/gkv468","volume":"43","author":"T Metsalu","year":"2015","unstructured":"Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 2015;43:W566\u2013570.","journal-title":"Nucleic Acids Res"},{"key":"1895_CR23","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1895_CR24","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1038\/nprot.2013.150","volume":"8","author":"S Wang","year":"2013","unstructured":"Wang S, Sun H, Ma J, Zang C, Wang C, Wang J, et al. Target analysis by integration of transcriptome and ChIP-seq data with BETA. Nat Protoc. 2013;8:2502\u201315.","journal-title":"Nat Protoc"},{"key":"1895_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","volume":"14","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Huang X, Ebert D, Mills C, Guo X, et al. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat Protoc. 2019;14:703\u201321.","journal-title":"Nat Protoc"},{"key":"1895_CR26","doi-asserted-by":"publisher","first-page":"D881","DOI":"10.1093\/nar\/gky1076","volume":"47","author":"FO Bagger","year":"2019","unstructured":"Bagger FO, Kinalis S, Rapin N. BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles. Nucleic Acids Res. 2019;47:D881\u20135.","journal-title":"Nucleic Acids Res"},{"key":"1895_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/j.1365-2141.2008.07261.x","volume":"142","author":"A Kohlmann","year":"2008","unstructured":"Kohlmann A, Kipps TJ, Rassenti LZ, Downing JR, Shurtleff SA, Mills KI, et al. An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase. Br J Haematol. 2008;142:802\u20137.","journal-title":"Br J Haematol"},{"key":"1895_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2011.01.004","volume":"144","author":"N Novershtern","year":"2011","unstructured":"Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, McConkey ME, et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell. 2011;144:296\u2013309.","journal-title":"Cell"},{"key":"1895_CR29","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","volume":"50","author":"M Gillespie","year":"2022","unstructured":"Gillespie M, Jassal B, Stephan R, Milacic M, Rothfels K, Senff-Ribeiro A, et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 2022;50:D687\u201392.","journal-title":"Nucleic Acids Res"},{"key":"1895_CR30","doi-asserted-by":"publisher","first-page":"D613","DOI":"10.1093\/nar\/gkaa1024","volume":"49","author":"M Martens","year":"2021","unstructured":"Martens M, Ammar A, Riutta A, Waagmeester A, Slenter DN, Hanspers K, et al. WikiPathways: connecting communities. Nucleic Acids Res. 2021;49:D613\u201321.","journal-title":"Nucleic Acids Res"},{"key":"1895_CR31","doi-asserted-by":"publisher","first-page":"D674","DOI":"10.1093\/nar\/gkn653","volume":"37","author":"CF Schaefer","year":"2009","unstructured":"Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, et al. PID: the pathway interaction database. Nucleic Acids Res. 2009;37:D674\u20139.","journal-title":"Nucleic Acids Res"},{"key":"1895_CR32","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.csbj.2020.05.018","volume":"18","author":"B H\u00f6llbacher","year":"2020","unstructured":"H\u00f6llbacher B, Bal\u00e1zs K, Heinig M, Uhlenhaut NH. Seq-ing answers: current data integration approaches to uncover mechanisms of transcriptional regulation. Comput Struct Biotechnol J. 2020;18:1330\u201341.","journal-title":"Comput Struct Biotechnol J"},{"key":"1895_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81000-5","volume":"11","author":"CE Bullerwell","year":"2021","unstructured":"Bullerwell CE, Robichaud PP, Deprez PML, Joy AP, Wajnberg G, D\u2019Souza D, et al. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex. Sci Rep. 2021;11:1537.","journal-title":"Sci Rep"},{"key":"1895_CR34","doi-asserted-by":"publisher","first-page":"eabg5003","DOI":"10.1126\/sciimmunol.abg5003","volume":"6","author":"L Calder\u00f3n","year":"2021","unstructured":"Calder\u00f3n L, Schindler K, Malin SG, Schebesta A, Sun Q, Schwickert T, et al. Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation. Sci Immunol. 2021;6:eabg5003.","journal-title":"Sci Immunol"},{"key":"1895_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ni1454","volume":"8","author":"C Cobaleda","year":"2007","unstructured":"Cobaleda C, Schebesta A, Delogu A, Busslinger M. Pax5: the guardian of B cell identity and function. Nat Immunol. 2007;8:463\u201370.","journal-title":"Nat Immunol"},{"key":"1895_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.immuni.2012.08.001","volume":"37","author":"S Li","year":"2012","unstructured":"Li S, Miao T, Sebastian M, Bhullar P, Ghaffari E, Liu M, et al. The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells. Immunity. 2012;37:685\u201396.","journal-title":"Immunity"},{"key":"1895_CR37","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.4049\/jimmunol.178.5.3031","volume":"178","author":"M Fuxa","year":"2007","unstructured":"Fuxa M, Busslinger M. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function. J Immunol. 2007;178:3031\u20137.","journal-title":"J Immunol"},{"key":"1895_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(01)00153-4","volume":"14","author":"M Horcher","year":"2001","unstructured":"Horcher M, Souabni A, Busslinger M. Pax5\/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 2001;14:779\u201390.","journal-title":"Immunity"},{"key":"1895_CR39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/44076","volume":"401","author":"SL Nutt","year":"1999","unstructured":"Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999;401:556\u201362.","journal-title":"Nature"},{"key":"1895_CR40","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1038\/emboj.2012.155","volume":"31","author":"R Revilla-I-Domingo","year":"2012","unstructured":"Revilla-I-Domingo R, Bilic I, Vilagos B, Tagoh H, Ebert A, Tamir IM, et al. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J. 2012;31:3130\u201346.","journal-title":"EMBO J"},{"key":"1895_CR41","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1038\/emboj.2011.140","volume":"30","author":"S McManus","year":"2011","unstructured":"McManus S, Ebert A, Salvagiotto G, Medvedovic J, Sun Q, Tamir I, et al. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J. 2011;30:2388\u2013404.","journal-title":"EMBO J"},{"key":"1895_CR42","doi-asserted-by":"crossref","unstructured":"Jackson TR, Ling RE, Roy A. The origin of B-cells: human fetal B cell development and implications for the pathogenesis of childhood acute lymphoblastic leukemia. Front Immunol. 2021 [cited 2022 Dec 5];12. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.637975.","DOI":"10.3389\/fimmu.2021.637975"},{"key":"1895_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood.V96.1.9","volume":"96","author":"TW LeBien","year":"2000","unstructured":"LeBien TW. Fates of human B-cell precursors. Blood. 2000;96:9\u201323.","journal-title":"Blood"},{"key":"1895_CR44","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1182\/blood-2015-08-665547","volume":"127","author":"R Gardner","year":"2016","unstructured":"Gardner R, Wu D, Cherian S, Fang M, Hanafi LA, Finney O, et al. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy. Blood. 2016;127:2406\u201310.","journal-title":"Blood"},{"key":"1895_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-017-0023-x","volume":"7","author":"E Mejstr\u00edkov\u00e1","year":"2017","unstructured":"Mejstr\u00edkov\u00e1 E, Hrusak O, Borowitz MJ, Whitlock JA, Brethon B, Trippett TM, et al. CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment. Blood Cancer J. 2017;7:1\u20135.","journal-title":"Blood Cancer J"},{"key":"1895_CR46","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/pbc.25953","volume":"63","author":"A Rayes","year":"2016","unstructured":"Rayes A, McMasters RL, O\u2019Brien MM. Lineage switch in MLL-rearranged infant leukemia following CD19-directed therapy. Pediatr Blood Cancer. 2016;63:1113\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"1895_CR47","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1182\/blood.2021015036","volume":"140","author":"R Tirtakusuma","year":"2022","unstructured":"Tirtakusuma R, Szoltysek K, Milne P, Grinev VV, Ptasinska A, Chin PS, et al. Epigenetic regulator genes direct lineage switching in MLL\/AF4 leukemia. Blood. 2022;140:1875\u201390.","journal-title":"Blood"},{"key":"1895_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/bjc.2014.622","volume":"112","author":"VT Baron","year":"2015","unstructured":"Baron VT, Pio R, Jia Z, Mercola D. Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer. Br J Cancer. 2015;112:755\u201364.","journal-title":"Br J Cancer"},{"key":"1895_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pharmthera.2012.09.001","volume":"137","author":"S Healy","year":"2013","unstructured":"Healy S, Khan P, Davie JR. Immediate early response genes and cell transformation. Pharmacol Ther. 2013;137:64\u201377.","journal-title":"Pharmacol Ther"},{"key":"1895_CR50","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1182\/blood.2019001289","volume":"134","author":"S O\u2019Byrne","year":"2019","unstructured":"O\u2019Byrne S, Elliott N, Rice S, Buck G, Fordham N, Garnett C, et al. Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs. Blood. 2019;134:1059\u201371.","journal-title":"Blood"},{"key":"1895_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/imr.12206","volume":"261","author":"S Boller","year":"2014","unstructured":"Boller S, Grosschedl R. The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function. Immunol Rev. 2014;261:102\u201315.","journal-title":"Immunol Rev"},{"key":"1895_CR52","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1073\/pnas.0907942107","volume":"107","author":"E Sanz","year":"2010","unstructured":"Sanz E, Mu\u00f1oz-A N, Monserrat J, Van-Den-Rym A, Escoll P, Ranz I, et al. Ordering human CD34+CD10-CD19+ pre\/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways. Proc Natl Acad Sci USA. 2010;107:5925\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1895_CR53","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1182\/blood.2021013442","volume":"139","author":"C Chen","year":"2022","unstructured":"Chen C, Yu W, Alikarami F, Qiu Q, Chen CH, Flournoy J, et al. Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia. Blood. 2022;139:2198\u2013211.","journal-title":"Blood"},{"key":"1895_CR54","first-page":"00248","volume":"S0301-472X","author":"W Liao","year":"2021","unstructured":"Liao W, Kohler ME, Fry T, Ernst P. Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia. Exp Hematol. 2021;S0301-472X:00248\u20134.","journal-title":"Exp Hematol"},{"key":"1895_CR55","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3324\/haematol.2018.206375","volume":"104","author":"A Agraz-Doblas","year":"2019","unstructured":"Agraz-Doblas A, Bueno C, Bashford-Rogers R, Roy A, Schneider P, Bardini M, et al. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis. Haematologica. 2019;104:1176\u201388.","journal-title":"Haematologica"},{"key":"1895_CR56","doi-asserted-by":"crossref","unstructured":"Khabirova E, Jardine L, Coorens THH, Webb S, Treger TD, Engelbert J, et al. Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia. Nat Med 2022;28:743\u2013751.","DOI":"10.1038\/s41591-022-01720-7"},{"key":"1895_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27270-z","volume":"12","author":"S Rice","year":"2021","unstructured":"Rice S, Jackson T, Crump NT, Fordham N, Elliott N, O\u2019Byrne S, et al. A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program. Nat Commun. 2021;12:6905.","journal-title":"Nat Commun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01895-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01895-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01895-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T20:30:15Z","timestamp":1686083415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01895-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1038\/s41375-023-01895-z","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}